Table 1.
Study | Study Type | CHD | Controls (N) | Cases (N) | DGE (N) 1 | Upregulated | Downregulated | GO (N) 2 | HPO (N) 3 | GO + HPO |
---|---|---|---|---|---|---|---|---|---|---|
GSE196443 | RNA-Seq | Trisomy 21/CHD | 5 | 5 | 23 | 23 | 0 | 2 | 0 | 0 |
GSE217557 | RNA-Seq | Trisomy 21/CHD | 32 | 50 | 13 | 12 | 1 | 0 | 0 | 0 |
GSE36761 | RNA-Seq | ToF 4 | 7 | 22 | 2228 | 727 | 1501 | 65 | 59 | 13 |
GSE132401 | RNA-Seq | ToF 4 | 5 | 5 | 111 | 69 | 42 | 6 | 5 | 4 |
GSE141955 | Microarray | ToF 4 | 6 | 9 | 35 | 2 | 33 | 0 | 0 | 0 |
GSE23959 | Microarray | HLHS 5 | 6 | 10 | 184 | 130 | 54 | 9 | 9 | 2 |
1 Differentially expressed genes identified. 2 Gene Ontology. 3 Human Phenotype Ontology. 4 Tetralogy of Fallot. 5 Hypoplastic Left Heart Syndrome.